While it might seem overvalued for a loss making company, u have to keep in mind they have been growing their revenue exponentially...and have top device for glaucoma..plus they have 2RT( check in other thread for details), which is already improved jn Europe...
- Forums
- ASX - By Stock
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
While it might seem overvalued for a loss making company, u have...
-
- There are more pages in this discussion • 308 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
-0.010(5.00%) |
Mkt cap ! $43.52M |
Open | High | Low | Value | Volume |
19.5¢ | 19.5¢ | 19.0¢ | $30.22K | 158.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 91577 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 36320 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 91577 | 0.190 |
6 | 156000 | 0.185 |
4 | 155561 | 0.180 |
4 | 25299 | 0.175 |
2 | 101400 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 151716 | 2 |
0.205 | 97633 | 2 |
0.210 | 243212 | 3 |
0.215 | 510482 | 8 |
0.220 | 2000 | 1 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |